Invisible ink tattoos could simplify breast cancer radiation
NCT ID NCT07095114
First seen Nov 01, 2025 · Last updated Jun 24, 2026 · Updated 27 times
Summary
This study tests a new tattoo ink called Magic Ink, which is only visible under ultraviolet light, for guiding daily radiation treatments in breast cancer patients. Researchers want to see if it is as safe and easy to use as standard tattoo ink. Thirty women with early-stage breast cancer will receive the Magic Ink tattoo and be followed for side effects and treatment setup ease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magic Ink (a UV-visible tattoo ink)
What this could lead to
If it works, this could make radiation treatment setup easier and less permanent for breast cancer patients.
What could go wrong
This is a small, early-phase trial with only 30 participants, so results may not apply widely. The ink might not stay visible or could cause skin reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.